Single high-dose MRI-guided radiation for intermediate prostate cancer
Part of Cancer, Kidney & urinary clinical trials.
This trial tests whether a single, image-guided radiation treatment can treat intermediate-risk prostate cancer while better protecting the urethra (the urine tube). It may help patients get effective cancer control with potentially fewer urinary side effects, depending on the results.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You agree to sign the study consent form.
- Your prostate cancer has been confirmed by biopsy as adenocarcinoma with ISUP grade 1 to 3.
- Your cancer must be localized intermediate-risk (not advanced), based on standard prostate cancer risk rules.
- Your PSA is 20 or less, and you have not taken hormone (anti-cancer) therapy before.
- Your MRI shows disease limited to the prostate (cT1c to cT2c) with no signs of spread to nearby lymph nodes or distant areas; age 18+ and able to do daily activities at level 0–2.
- Your urinary symptoms score (IPSS) is 15 or less, and you can safely have required devices (like a Foley catheter and a rectal balloon) during treatment; prostate size estimate must be 100 grams or less.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a precise, MRI-guided radiation treatment given over 7 days for people with prostate cancer in specific risk categories. It may help shrink or control the cancer while carefully targeting the tumor.
This trial tests a stronger, more focused radiation dose to the main tumor inside the prostate using MRI guidance. It aims to improve control of intermediate-risk prostate cancer while possibly reducing side effects.
This trial tests a precise, short course of radiation therapy guided by MRI for men with low or favorable intermediate-risk prostate cancer. It aims to offer effective treatment with fewer sessions and fewer side effects.
This trial tests a type of focused radiation therapy for men with intermediate or high-risk prostate cancer that hasn't spread. It aims to improve outcomes by targeting the main tumor seen on MRI.
This trial tests a newer, more precise radiation treatment that gives a higher dose to the main tumor while keeping radiation to the rest of the prostate the same. It is for men with intermediate- or high-risk prostate cancer who haven't had prior prostate radiation or removal.
This trial tests whether using MRI scans to guide radiation can allow lower doses to the healthy parts of the prostate, potentially reducing side effects. It is for men with intermediate- or high-risk prostate cancer that can be seen on MRI and has not spread.
Hear when a new Prostate cancer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.